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A b s t r a c t 
Patients of Diabetes Mellitus-type 2 (DM-2) is not only characterized by 
an increase of blood glucose levels, but also it is characterized by 
polyphagia and weight loss. This research aimed to discover the 
potential of 80% ethanol extract of Indonesia Nigella sativa L. (black 
cumin) seeds to the feed consumption level and changes in body weight 
of DM-2 rats model due to the administration of High Fat Diet (HFD) 
followed by the induction of streptozotocin (STZ) in a dose of 30 mg/kg 
Body Weight (BW). The DM-2 rats as the induction results divided into 
five groups, it was given a treatment using N. sativa extract with 
different doses, i.e. 0, 24, 48 and 72 mg/kg BW (DM-0, DM-24, DM-48, DM-
72), positive control used metformin 45 mg/kg BW (DM-Metf). Non-DM 
rats (Normal)  used as reasonable control. HFD induction carried out for 
14 weeks, and N. sativa therapy conducted for four weeks after the oral 
glucose tolerance test. During the treatment, an observation of the feed 
consumption level and weekly weight gain were carried out. The data 
obtained were tested using one-way ANOVA, and it continued by Duncan 
Multiple Rank Test (DMRT), α= 5%. The research results indicated that the 
administration of 80% ethanol extract Indonesia N. sativa using the doses 
of 24 mg/kg BW and 48 mg/kg BW can control the feed consumption 
levels and prevent significant weight loss (p<0.05). 
1. INTRODUCTION 
More than 90% of Diabetes Mellitus-type2 
(DM-2) patients are suffered by those who are 
obese [1]. The DM-2 of non-obesity often 
found in European and Asian countries [2]. 
Several types of research shows that people 
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with DM-2 who have average weight have 
more visceral fat. The abdominal fat release a 
hormone that affects glucose metabolism and 
interferes with fat metabolism. The belly fat 
can make a person's typical metabolic profile 
looks like someone's profile that is overweight, 
maybe even they looked slim. However, 
visceral fats are closely related to the 
occurrence of insulin resistance, including slim 
individuals [3]. 
Both DM-2 obese and non-obese have the 
same pathogenesis due to a decrease in insulin 
production; the cells also proficiency insulin 
resistance [4; 5]. There is a slight difference 
between the two, in which the DM-2 of non-
obesity in a decrease of insulin production and 
insulin resistance occurs not as massive in the 
DM-2 obesity [2]. The reduction of insulin level 
and even insulin resistance causes the cells to 
experience glucose deficiency as a source of 
energy through the levels in the blood are very 
high. Limitations of glucose in cells of DM 
patients force lipolysis of adipocyte cells, 
release energy deposits into the circulation 
and hepatocytes that perform 
gluconeogenesis [6; 7]. Even though the DM 
patients are suffering often accompanied by 
polyphagia, decreased digestive efficiency and 
increased gluconeogenesis, it causes on the 
weight loss [8]; hence, the body of DM 
patients quickly becomes very emaciated, 
especially in DM-2 of non-obesity.  
Weakened insulin production and 
physiological function in both types of DM-2 
have the same general principle of treatment, 
namely increasing insulin production and 
decreasing insulin  resistance to reduce blood 
glucose levels. However, there are slightly 
different parameters between the two. Since 
in the DM-2 obesity is triggered by being 
overweight, one of therapies of DM-2 obesity 
is by carrying out weight loss [9; 10], whereas 
therapy of DM-2 of non-obesity is expected to 
be able to decrease the blood glucose levels 
accompanied by weight loss recovery. 
Nevertheless, weight normalization is an 
indicator that accompanies the success of 
therapy all diabetes.  
Consumption of black cumin seeds 
customarily has been reported to the public 
and laboratory tests related to N. sativa as an 
antioxidant, antibacterial, anti-fungal, anti-
cancer, anti-inflammatory, antiallergic, 
hepatoprotector [11], antifertility [12]. The 
ethanol extract of N. sativa seeds can decrease 
blood glucose levels and able to improve the 
lipid profile of serum DM-2 rats [13]. 
Thymoquinone is the main active compound in 
N. sativa as an antidiabetic, one of which is 
through its potential to reduce liver 
gluconeogenesis [14]. However, the potential 
of N. sativa in improving weight loss for those 
who are DM-2 patients still requires empirical 
data from laboratories. This research aims to 
discover the effectivity of N. sativa seeds 
extract as antidiabetic, in which it is indicated 
through the existence of decreased feed 
consumption, increased digestive efficiency, to 
the increased weight loss in DM-2 rats. 
 
2. MATERIALS AND METHODS 
Study area 
The animals model used are Rattus 
norvecicus  starin wistar male, 3-4 months old, 
150-200 g body weight obtained from the 
Integrated Research and Testing Laboratory of 
Gajah Mada University, Yogyakarta. The N. 
sativa seeds obtained from Balitro, Bogor, 
Indonesia and the metformin was from Kimia 
Farma, Indonesia. Rat feed of Broiler feed-1 
(BR-1) was from Pokphand, Indonesia, and 
Streptozotocin (STZ, Merck). 
 
Research design 
The DM-2 rats divided into five groups 
using the treatment extract of N. sativa seeds, 
in which the doses were different, i.e. doses of 
0 mg/kg BW, 24 mg/kg BW, 48 mg/kg BW, 72 
mg/kg BW (DM-0, DM-24, DM-48, DM-72), 
metformin 45 mg/kg BW (DM-Metf), and 
control of non DM (Normal). The rats' group of 
DM-0 and Non-DM got 2.5 ml Na-CMC 0.5%. The 
treatment was given orally for four weeks. 
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Induction of DM-2 
After acclimation for two weeks, it 
continued by inducing the DM-2 with HFD 
administration (BR-1: cow fats = 2:1, 40 
g/head/day) [15]  for eleven weeks; 
furthermore, the intraperitoneal injection of 
STZ (in the citrate buffer of 0.01, pH 4.5)  
carried out using the doses of 30 mg/kg BW in 
twice in the 10th and 11th weeks of the HFD 
induction period. Glucose tolerance test 
carried out on day five after the last STZ 
injection. The rats used as the examination 
samples had a minimal glucose level of 200 
mg/dl [16]. 
 
Extract Preparation  
The seeds of N. sativa were dried up using 
an oven in 40 oC for 2x24 hours, and the 
powder were mashed and sieved using a 60-
mesh sieve until subtle powder obtained. The 
triturate were soaked in 80% alcohol  (1:5 = b: 
v) for 24 hours repeatedly until the filtrate was 
clear. The filtrate evaporated using a vacuum 
rotary evaporator at 40 oC , the concentrated 
extract obtained. 
 
Treatment and Data Collection 
The rats maintained in the individual cage. 
The daily temperature as room temperature of 
22 oC to 25 oC,  lighting with twelve hours of 
dark and twelve hours of light. The feeds were 
given dayli or 40 grams each, and the drinking 
water was given in ad libitum. Weighting the 
remaining feeds was carried out everyday, the 
body weighting carried out once a week. The 
data collected during the research were as 
follows:  
Weekly Feed Consumption, it was carried 
out by adding up the amount of daily feed 
consumption for seven days during sixteen 
weeks of the research.   
Weekly Weight Gain, it was carried out by 
subtracting the final body weight with early 
week weight for sixteen weeks of research. 
Data Analysis 
The data were analyzed statistically using 
the SPSS ver. 16 software. The data which had 
a normal distribution and homogenous 
variants (Kolmogorov-Smirnov and Levene 
tests) were analyzed using one-way ANOVA; 
then, it followed by the DMRT test, α=5%. 
 
3. RESULTS  
The research result indicated that the data 
normally distributed and it had homogenous 
data variants (p>0.05). The results of the 
ANOVA test produced the value of p<0.01. At 
the same time, the results of the DMRT test 
showed that the treatments of DM-24 and DM-
48 gave the best results to improve the feed 
consumption levels of DM-2 rats.  The effect 
was as good as the treatment of  DM-Metf 
until the feed consumption rate was the same 
as the normal rats (Table 1, Figure 1). On the 
DM-0 rats group, the feed consumption level 
continued to increase until the end of the 
study. 
 
Table 1. The results of Duncan Test on the Average of Feed Consumption Level and Body Weight of Rats 
(Rattus norvegicus) of Diabetes Mellitus-type 2 Model. 
Treatment  Feed consumption mean ± SD (g) Body weight mean ± SD (g) 
Normal 208.50 ± 1.93c 335.38 ± 30.90d 
DM-Metf.  229.06 ± 2.98bc 307.25 ± 21.06bcd 
DM-0 237.44 ± 1.27a 256.00 ± 33.25a 
DM-24 202.44 ± 3.08abc 296.00 ± 33.83bc 
DM-48 203.81 ± 8.27c 323.63 ± 35.49cd 
DM-72 232.81 ± 4.13ab 265.06 ± 11.11ab 
Description: Different notations showed significant differences, p= <0.05 
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The research result indicated that the data 
normally distributed and it had homogenous 
data variants (p>0.05). The results of ANOVA 
test showed that the 80% ethanol  extract of 
Indonesia N. sativa  was very significant 
(p<0.01) affected to body weight of R. 
norvegicus with diabetes mellitus-type 2 model. 
Furthermore, the results of the DMRT test 
showed that the treatment of DM-48 gave the 
best results to improve the body weight of 
DM-2 rats, the effect was as good as the 
treatment of DM-Metf,  only the DM-48 and 
DM-Metf treatments which had the similar 
dody weight but not the same as the normal 
body weight  (Table 1, Figure  2). 
 
 
Figure 1. Feed Consumption Levels of Diabetes 
Mellitus-Type 2 Rats Model 
 
 
Figure 2. Body Weight of Diabetes Mellitus-Type 2 
Rats Model 
4. Discussion 
The HFD feed initially less favoured by the 
rats (Figure 1 weeks 1 to 8), yet the preference 
of HFD-diet continued to increase over time. 
The STZ injection on all of the DM rats starting 
from week 10 increased the feed consumption 
numbers, which exceeded the normal rats 
(Figure 1). This result in line with the findings 
reported that there is a powerful correlation 
between DM and polyphagia [17]. This is due to 
the pancreas DNA of DM rats that oxidized and 
apoptotic [15]; thus, the insulin production is 
reduced [18]. Insulin limitations caused cells 
unable to take glucose from the blood, lack of 
energy on cells, cells sent signals to the 
hypothalamus that the cells required energy 
intake which manifestated as starvation and 
showed the level of food consumption 
exceeded the normal at 11-14 weeks.  
The treatment use black cumin extract on 
this enquiry results could suppress and 
normalize the feed consumption levels (Table 
1, Figure 1). The use of ethanol extract of N. 
sativa the doses of 24 and 48 mg/kg BW for 
twenty-eight days in this study was the best 
way to affect the feed consumption levels so 
that it was the same as the effects of the 
standard drug metformin even to the same as 
normal rats. This finding was accordance with 
a research report N. sativa treatment in 
improving the rats body weight through a 
therapy compared to the DM rats of non-
treatment. This condition is due to 
improvements in the structure of the pancreas 
[19]. The consumption of N. sativa also 
rectified the insulin functional; this was 
coherent to the statement that the 
consumption of N. sativa oils in 3 g/day for the 
DM patients during 12 weeks can slightly 
reduce the insulin resistance and dietary intake 
[20]. 
Typically, high feed consumption level 
enhanced the weight gain. However, in the 
DM-2 rats model was inversely proportional, 
the feed consumption of diabetic rats (DM-0) 
which was high had low body weight (Table 1), 
the body weight of the DM-0 group rats 
continued to decline until the end of the 
research (Figure 1 week 11 to 14). This result 
was in accordance with the fact of weight loss 
in individuals who suffered from the DM-2 [21; 
8].  
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Diabetic rats in this research experienced 
not only polyphagia but also weight loss (Table 
1, Figure 2). This result relative to those 
experienced by diabetics in general [22]. This 
study also indicated the feed efficiency that 
was very low because of glucose of absorption 
results and the results of gluconeogenesis as 
the body's response to low glucose level. The 
energy source in cells could not be utilized 
properly. The DM rats experienced 
thermodynamic balance disorder and 
efficiency of energy [23]. 
The N. sativa extract treatment in this 
examination could prevent weight loss and 
could normalize it. This results were better 
than the finding on the therapy of 
thymoquinone 10 mg/kg BW on male diabetic 
rats for 32 days that could not prevent the 
weight loss [24]. The DM-48 dose in this inquiry 
could increase the body weight so that it was 
the same as the normal rats (Table 1, Figure 2). 
This finding powered by a report that 
thymoquinone, carvacrol, t-anethole and even 
4-terpineol in N. sativa, also used as an 
excellent free radical scavenger [25]. 
Thymoquinone acted as an antioxidant to 
prevent oxidative stress of pancreatic beta 
cells and body cells [26]. Another research 
reported that the N. sativa able to improve the 
proliferation and regeneration of pancreatic 
beta cells that had damaged and it played by 
thymoquinone [27; 28].  
Furthermore, the enhancement of 
consumption of DM-48 rats in this study also 
reinforced by the research results which 
proved that the N. sativa could rectify the 
structure and physiological function of rats 
pancreas of DM-24 and DM-48. The ethanol 
extract of N. sativa improved the insulin 
secretion from pancreas [29], and the insulin 
sensitivity of Guinea Pigs Non-Insulin-
Dependent Diabetic (NIDDM) [30]. Another 
researcher also reported similar findings that 
the N. sativa oils improved the signalling and 
could prevent the degradation of the insulin 
enzyme [31]. The increasing of insulin 
production and functional could facilitate the 
transportation of glucose from the circulation 
so that the glucose requirements in 
congregation the energy needs and other 
related to the metabolisms in various cells and 
tissues were improving. This condition allowed 
the cells and tissues to grow so that there was 
an amendment on the body weight. The 
research findings were coherent with a report 
on the insulin therapy that could improve the 
body weight of DM-2 patients [32]. Hence, the 
normalization of the structure and function of 
the pancreas by N. sativa extract can facilitate 
the transport of glucose into cells. This 
amelioration was followed by optimize the 
glucose in the blood to be regenerated into 
energy so that there is a decrease in the feed 
consumption level,  and finally increase the 
body weight of rats that given the treatment 
of N. sativa. 
 
5. CONCLUSION 
The extract of black cumin (Nigella sativa, 
L.) has a potential to prevent the occurrence of 
polyphagia and it can normalize the feed 
consumption levels to prevent the weight loss 
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